PLAC1: A Protein Essential for Fetal Growth and Development (G10761)

Target Name: PLAC1

NCBI ID: G10761

PLAC1

PLAC1: A Protein Essential for Fetal Growth and Development

The placenta plays a vital role in the development and growth of fetuses, and it is also involved in the production of several important hormones and proteins that are essential for fetal growth and development. The placenta is a complex structure that consists of several layers of cells, including the endothelial cells, the uterine lining, and the fetal tissue.

One of the key proteins produced by the placenta is PLAC1 (placenta-specific 1), which is a transmembrane glycoprotein that is expressed in the endothelial cells of the placenta. PLAC1 is a protein that is composed of four exons, and it has a calculated molecular weight of approximately 180 kDa.

PLAC1 is expressed in the endothelial cells of the placenta and is involved in several important functions, including the production of several growth factors that are essential for fetal growth and development. PLAC1 has been shown to play a key role in the production of the growth factor FGF-1, which is a vital factor for the growth and development of tissues in the fetus.

In addition to its role in the production of growth factors, PLAC1 is also involved in the regulation of several important signaling pathways that are involved in fetal growth and development. For example, PLAC1 has been shown to play a key role in the regulation of the Wnt signaling pathway, which is a critical pathway that is involved in the development and growth of tissues in the fetus.

PLAC1 has also been shown to be involved in the regulation of theNotch signaling pathway, which is also involved in fetal growth and development. TheNotch signaling pathway is a critical pathway that is involved in the regulation of stem cell proliferation and the development of tissues in the fetus.

PLAC1 is also involved in the regulation of several other signaling pathways that are important for fetal growth and development, including the TGF-β signaling pathway, the Hedgehog signaling pathway, and the FGF-2 signaling pathway.

PLAC1 is a protein that has been shown to play a critical role in the regulation of fetal growth and development. As a result, PLAC1 has been identified as a potential drug target for several pharmaceutical companies. Currently, there are several PLAC1-based drugs that are being developed for use in the treatment of various diseases, including cancer, genetic disorders, and reproductive diseases.

In addition to its potential as a drug target, PLAC1 is also a valuable biomarker for the diagnosis and prognosis of several diseases. For example, PLAC1 has been shown to be downregulated in several types of cancer, including breast cancer and ovarian cancer. This suggests that PLAC1 may be a useful biomarker for the diagnosis and prognosis of these types of cancer.

PLAC1 is also a potential biomarker for the diagnosis and prognosis of genetic disorders, such as Down syndrome. As PLAC1 is expressed in the endothelial cells of the placenta, it is possible that PLAC1 may be used as a biomarker for the diagnosis of Down syndrome, which is a genetic disorder that is characterized by the absence of a specific chromosome 21.

In addition to its potential as a drug target and biomarker, PLAC1 is also an important protein that is involved in the regulation of fetal growth and development. The production of PLAC1 by the placenta is essential for the growth and development of the fetus, and it is possible that PLAC1 may be involved in the regulation of several important signaling pathways that are involved in fetal growth and development.

Overall, PLAC1 is a protein that has been shown to play a critical role in the regulation of fetal growth and development. As a result, PLAC1 has

Protein Name: Placenta Enriched 1

Functions: May play a role in placental development

The "PLAC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLAC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets